Literature DB >> 20953619

Ranibizumab for retinal arterial macroaneurysms.

Roberto Gallego-Pinazo, Sebastián Martínez-Castillo, J Fernando Arévalo, Manuel Díaz-Llopis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20953619     DOI： 10.1007/s00417-010-1543-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  5 in total

1.  Intravitreal ranibizumab in retinal macroaneurysm.

Authors:  Andrea R Wenkstern; Heike Petersen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-05-28       Impact factor: 3.117

2.  Intravitreal bevacizumab for macular edema secondary to retinal macroaneurysm.

Authors:  B Chanana; R V Azad
Journal:  Eye (Lond)       Date:  2008-04-04       Impact factor: 3.775

3.  Ranibizumab for neovascular age-related macular degeneration.

Authors:  Philip J Rosenfeld; David M Brown; Jeffrey S Heier; David S Boyer; Peter K Kaiser; Carol Y Chung; Robert Y Kim
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

4.  Acquired arterial macroaneurysms of the retina.

Authors:  R A Lewis; E W Norton; J D Gass
Journal:  Br J Ophthalmol       Date:  1976-01       Impact factor: 4.638

5.  Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study.

Authors:  Alexander Rouvas; Petros Petrou; Ioannis Vergados; Dimitrios Pechtasides; Vasilios Liarakos; Maria Mitsopoulou; Ioannis Ladas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-16       Impact factor: 3.117
  5 in total
  2 in total

1.  The use of bevacizumab in a multilevel retinal hemorrhage secondary to retinal macroaneurysm: a 39-month follow-up case report.

Authors:  Dimitrios Tsakpinis; Mayssa B Nasr; Paris Tranos; Nikos Krassas; Theodoros Giannopoulos; Chrysanthos Symeonidis; Stavros A Dimitrakos; Anastasios Gp Konstas
Journal:  Clin Ophthalmol       Date:  2011-10-12

2.  Foveal Exudative Macroaneurysm Treated with Intravitreal Ranibizumab.

Authors:  Carlos Menezes; Rui Carvalho; Carla Teixeira; José Alberto Lemos; Rita Gonçalves; Pedro Coelho; André Lima
Journal:  Case Rep Ophthalmol       Date:  2015-06-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.